R3 Vascular

Mountain View, CA · Founded 2019 · Privately Held (backing)

Developer of medical metallic stents devices designed to treat peripheral arterial diseases. R3 Vascular is based in Mountain View, CA and was founded in 2019. Its last known valuation is $145 million. It has raised $106 million across 2 recorded rounds; the latest was a $72.5 million later-stage round in Apr 2024.

Last price · $/share
—
Implied valuation
$145.0M
Total raised
$105.6M
Last round
Later Stage VC
Apr 2024
Cap table — not yet on record

R3 Vascular's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of R3 Vascular with a free account
  • ·Watch R3 Vascular: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about R3 Vascular

Where does R3 Vascular's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across R3 Vascular's 2 recorded funding rounds.